Cytopia
Recent developments announced by Cytopia
Published in Health Insurance Week, September 9th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Cytopia.
Report 1: Cytopia Limited (ASX:CYT) announced today the formation of an oncology clinical advisory panel to guide future development of CYT997, the company's lead small-molecule vascular-disrupting agent (VDA), into Phase II development. The Panel will also assist the company with planning for its other anticancer programmes.
The advisory panel is comprised of eminent medical oncologists from the United States with extensive drug development and regulatory experience. Two leading...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Insurance Week
More Articles from Health Insurance Week
- Biotech Business
Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel - Cigna Behavioral Health
CIGNA Behavioral Health's Employee Assistance Program Recognized for Third Consecutive Year as the 'Readers Choice' for the Best Overall EAP by Business Insurance - Adverse Drug Reactions
Researchers at Oregon State University target adverse drug reactions - Aetna
Aetna Signs Agreement with Finger Lakes Health - Biomedicine
HealthGate Helps Hospitals Address Medicare's End of Coverage for Preventable Errors - Biomedicine
NeoStem Announces Milestone Patent Filing Establishing Model for Next Generation Bio-Medical Infrastructure - More from this issue of Health Insurance Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
